Get started
Author

Susana Monroy

Observed names: Monroy-Santoyo Susana, S Monroy-Santoyo, S. Monroy, S. Monroy-Santoyo, S. Monroy‐Santoyo, Susana Monroy-Santoyo, Susana Monroy-Santoyo
ORCID: 0000-0002-0337-0205
Observed ORCID: 0000-0002-0337-0205
OpenAlex ID: A5015235815
Genetic Testing to Inform Epilepsy Treatment Management From an International Study of Clinical Practice
2022 · Dianalee McKnight, Ana Morales, et al. · JAMA Neurology · 95
PDF
Efficacy and safety of givosiran for acute hepatic porphyria: 24‐month interim analysis of the randomized phase 3 ENVISION study
2021 · Paolo Ventura, Herbert L. Bonkovsky, et al. · Liver International · 84
PDF
Efficacy and safety of givosiran for acute hepatic porphyria: Final results of the randomized phase III ENVISION trial
2023 · David J. Kuter, Herbert L. Bonkovsky, et al. · Journal of Hepatology · 55
PDF
Higher incidence of thyroid agenesis in Mexican newborns with congenital hypothyroidism associated with birth defects
2011 · Susana Monroy-Santoyo, Isabel Ibarra-González, et al. · Early Human Development · 23
Tyrosinemia type I: clinical and biochemical analysis of patients in Mexico
2014 · Cynthia Fernández-Lainez, Isabel Ibarra-González, et al. · Annals of Hepatology · 22
PDF
Phenylalanine hydroxylase deficiency in Mexico: genotype–phenotype correlations, BH4 responsiveness and evidence of a founder effect
2014 · M. Vela‐Amieva, M. Abreu‐González, et al. · Clinical Genetics · 18
EXPLORE B: A prospective, long‐term natural history study of patients with acute hepatic porphyria with chronic symptoms
2022 · David Cassiman, Raili Kauppinen, et al. · Journal of Inherited Metabolic Disease · 17
PDF
Causes of delay in referral of patients with phenylketonuria to a specialized reference centre in Mexico
2011 · M Vela-Amieva, I Ibarra-González, et al. · Journal of Medical Screening · 17
Inborn Errors of Intermediary Metabolism in Critically Ill Mexican Newborns
2014 · Ibarra-González Isabel, Fernández-Lainez Cynthia, et al. · Journal of Inborn Errors of Metabolism and Screening · 15
PDF
Caracterización de errores innatos del metabolismo intermediario en pacientes mexicanos
2013 · I. Ibarra-González, C. Fernández-Lainez, et al. · Anales de Pediatría · 11
Twelve-month interim analysis of efficacy and safety of givosiran, an investigational RNAi therapeutic for acute hepatic porphyria, in the envision open label extension
2020 · Eliane Sardh, Manisha Balwani, et al. · Journal of Hepatology · 5
Modelo de atención inicial de la fenilcetonuria y otras hiperfenilalaninemias en el Instituto Nacional de Pediatría
2010 · Marcela Vela-Amieva, Isabel Ibarra‐González, et al. · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · 5
Case report: Functional characterization of a de novo c.145G>A p.Val49Met pathogenic variant in a case of PIGA-CDG with megacolon
2022 · Roberta Salinas-Marín, Yoshiko Murakami, et al. · Frontiers in Genetics · 4
PDF
Low allelic heterogeneity in a sample of Mexican patients with classical galactosaemia
2008 · J. Velázquez‐Aragón, M. A. Alcántara‐Ortigoza, et al. · Journal of Inherited Metabolic Disease · 4
S1169 Twelve-Month Interim Analysis of Efficacy and Safety of Givosiran, an Investigational RNAi Therapeutic for Acute Hepatic Porphyria, in the ENVISION Open Label Extension
2020 · Eliane Sardh, Manisha Balwani, et al. · The American Journal of Gastroenterology · 3
Historia de la fenilcetonuria
2011 · Marcela Vela-Amieva, Isabel Ibarra‐González, et al. · Redalyc (Universidad Autónoma del Estado de México) · 3
S1170 Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyria: 24-Month Interim Analysis of the Phase 3 ENVISION Randomized Clinical Trial
2021 · Herbert L. Bonkovsky, Paolo Ventura, et al. · The American Journal of Gastroenterology · 2
Description of Sensor Placement for Continuous Glucose Monitoring in a Pig Model of Diabetes Mellitus
2025 · Beatriz E Pérez-Guillé, Rosa E Soriano-Rosales, et al. · Journal of the American Association for Laboratory Animal Science · 1
385: Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyria: 36-month Results of the Phase 3 Envision Randomized Clinical Trial
2022 · Manish Thapar, Herbert L. Bonkovsky, et al. · Gastroenterology · 1
Tratamiento de urgencia de la acidemia metilmalónica
2012 · Enrique Santillán-Aguayo, Nuria Revilla-Estivil, et al. · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · 1
Givosiran treatment over 36 months for people with acute hepatic porphyria: a plain language summary
2026 · Kristen Wheeden, Sue Burrell, et al. · Future Rare Diseases
Acute hepatic porphyrias in Mexico: A tale of challenges and achievements facing rare diseases
2026 · Susana Monroy, Jose Francisco González-Zamora · Molecular Genetics and Metabolism
Su2144 EXPLORE B POST HOC ANALYSIS OF CHRONIC SYMPTOMS IN PATIENTS WITH ACUTE HEPATIC PORPHYRIA
2026 · Susana Monroy, Manish Thapar, et al. · Gastroenterology
Su2144 EXPLORE B POST HOC ANALYSIS OF CHRONIC SYMPTOMS IN PATIENTS WITH ACUTE HEPATIC PORPHYRIA
2026 · Susana Monroy, Manish Thapar, et al. · Gastrointestinal Endoscopy
1279: Dimension Analysis of Eq-5d in Patients With Acute Hepatic Porphyria Categorized by Annualized Attack Rate to Assess Any Relationship With Symptoms Occurring Between Attacks
2025 · Manisha Balwani, Manish Thapar, et al. · Gastroenterology
Works count: 32
Citation count: 385
H-index: 10
I10-index: 10
Year
Topic
Type